These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21030422)

  • 1. Diagnosing and responding to violations in the positivity assumption.
    Petersen ML; Porter KE; Gruber S; Wang Y; van der Laan MJ
    Stat Methods Med Res; 2012 Feb; 21(1):31-54. PubMed ID: 21030422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal inference in epidemiological studies with strong confounding.
    Moore KL; Neugebauer R; van der Laan MJ; Tager IB
    Stat Med; 2012 Jun; 31(13):1380-404. PubMed ID: 22362629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing positivity violations in causal effect estimation using Gaussian process priors.
    Zhu AY; Mitra N; Roy J
    Stat Med; 2023 Jan; 42(1):33-51. PubMed ID: 36336460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causal effect models for realistic individualized treatment and intention to treat rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 3. PubMed ID: 19122793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invited commentary: positivity in practice.
    Westreich D; Cole SR
    Am J Epidemiol; 2010 Mar; 171(6):674-7; discussion 678-81. PubMed ID: 20139125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On model selection and model misspecification in causal inference.
    Vansteelandt S; Bekaert M; Claeskens G
    Stat Methods Med Res; 2012 Feb; 21(1):7-30. PubMed ID: 21075803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double Robust Efficient Estimators of Longitudinal Treatment Effects: Comparative Performance in Simulations and a Case Study.
    Tran L; Yiannoutsos C; Wools-Kaloustian K; Siika A; van der Laan M; Petersen M
    Int J Biostat; 2019 Feb; 15(2):. PubMed ID: 30811344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marginal structural models and causal inference in epidemiology.
    Robins JM; Hernán MA; Brumback B
    Epidemiology; 2000 Sep; 11(5):550-60. PubMed ID: 10955408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core concepts in pharmacoepidemiology: Violations of the positivity assumption in the causal analysis of observational data: Consequences and statistical approaches.
    Zhu Y; Hubbard RA; Chubak J; Roy J; Mitra N
    Pharmacoepidemiol Drug Saf; 2021 Nov; 30(11):1471-1485. PubMed ID: 34375473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A More Efficient Causal Mediator Model Without the No-Unmeasured-Confounder Assumption.
    Brandt H
    Multivariate Behav Res; 2020; 55(4):531-552. PubMed ID: 31497999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On adaptive propensity score truncation in causal inference.
    Ju C; Schwab J; van der Laan MJ
    Stat Methods Med Res; 2019 Jun; 28(6):1741-1760. PubMed ID: 29991330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of methods to estimate the survivor average causal effect in the presence of missing data: a simulation study.
    McGuinness MB; Kasza J; Karahalios A; Guymer RH; Finger RP; Simpson JA
    BMC Med Res Methodol; 2019 Dec; 19(1):223. PubMed ID: 31795945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causal inference accounting for unobserved confounding after outcome regression and doubly robust estimation.
    Genbäck M; de Luna X
    Biometrics; 2019 Jun; 75(2):506-515. PubMed ID: 30430543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models.
    Kyle RP; Moodie EE; Klein MB; Abrahamowicz M
    Am J Epidemiol; 2016 Aug; 184(3):249-58. PubMed ID: 27416840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference.
    Murray EJ; Robins JM; Seage GR; Freedberg KA; Hernán MA
    Am J Epidemiol; 2017 Jul; 186(2):131-142. PubMed ID: 28838064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical learning of origin-specific statically optimal individualized treatment rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 6. PubMed ID: 19122792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding and diagnosing the potential for bias when using machine learning methods with doubly robust causal estimators.
    Bahamyirou A; Blais L; Forget A; Schnitzer ME
    Stat Methods Med Res; 2019 Jun; 28(6):1637-1650. PubMed ID: 29717941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling for continuous confounders in epidemiologic research.
    Brenner H; Blettner M
    Epidemiology; 1997 Jul; 8(4):429-34. PubMed ID: 9209859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.
    Hernán MA; Brumback B; Robins JM
    Epidemiology; 2000 Sep; 11(5):561-70. PubMed ID: 10955409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.